Table 2.
Disease model | Inducer | Anesthetics | Effects | Reference |
---|---|---|---|---|
Cardiac ischemia in rat myocyte | Hypoxia | Isoflurane | Antioxidant effects | [32] |
Hydrogen peroxide | Antiapoptosis effects | |||
Neutrophil | Cardioprotective effects | |||
| ||||
Cerebral ischemia in rats | Cerebral artery occlusion | Sevoflurane, isoflurane | Antioxidant effects | [33] |
Anti-inflammatory effects | ||||
| ||||
Diabetic rats | Mutation in the leptin receptor gene |
Isoflurane | Antioxidant effects | [34] |
Decreased myocardial contraction | ||||
| ||||
MODS in mice | Zymosan | Isoflurane | Anti-inflammatory effects | [18] |
| ||||
MODS in mice | Zymosan | Isoflurane | Anti-inflammatory effects | [35] |
| ||||
MODS in mice | Zymosan | Isoflurane | Antiapoptosis effects | [36] |
Anti-inflammatory effects | ||||
| ||||
Inflammation in rats | LPS | Sevoflurane | Anti-inflammatory effects | [37] |
| ||||
Inflammation in rats | LPS | Isoflurane | Anti-inflammatory effects | [38] |
| ||||
Sepsis in mice | Cecal ligation and puncture | Sevoflurane | Anti-inflammatory effects | [39] |
| ||||
Sepsis in rat | Cecal ligation and puncture | Sevoflurane, isoflurane | Anti-inflammatory effects | [40] |
| ||||
Rat liver transplantation | — | Sevoflurane | Antioxidant effects | [41] |
MODS, multiple organ dysfunction syndrome; LPS, lipopolysaccharide.